The effects of hormone therapy on metabolic risk factors in postmenopausal Korean women (Q38483271)

3 September 2017

The effects of hormone therapy on metabolic risk factors in postmenopausal Korean women (English)

1 reference

3 September 2017

S M Kim

1

1 reference

3 September 2017

S H Kim

2

1 reference

3 September 2017

J R Lee

3

1 reference

3 September 2017

B C Jee

4

1 reference

3 September 2017

S-Y Ku

5

1 reference

3 September 2017

C S Suh

6

1 reference

3 September 2017

Y M Choi

7

1 reference

3 September 2017

J G Kim

8

1 reference

3 September 2017

S Y Moon

9

1 reference

3 September 2017

23 July 2010

1 reference

3 September 2017

1 reference

3 September 2017

14

1 reference

3 September 2017

1

1 reference

3 September 2017

66-74

1 reference

The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.

3 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Associations between metabolic syndrome and mortality from cardiovascular disease in Japanese general population, findings on overweight and non-overweight individuals. Ibaraki Prefectural Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

The relationship between reproductive factors and metabolic syndrome in Korean postmenopausal women: Korea National Health and Nutrition Survey 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

The emergence of the metabolic syndrome with menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

The effect of menopause on the metabolic syndrome among Korean women: the Korean National Health and Nutrition Examination Survey, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Appropriate waist circumference cutoff points for central obesity in Korean adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Cholesterol, diabetes and major cardiovascular diseases in the Asia-Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Postmenopausal hormone therapy and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

Serum C-reactive protein and plasma homocysteine levels are associated with hormone therapy use and other factors: a population-based study of middle-aged Australian-born women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2010.498593

10.3109/13697137.2010.498593

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference